Table 2. FPG and HbA1c Changes from Baseline.

Parameters	Drugs	Change (baseline vs. end of treatment)		p value among drugs†
		Median (Q1–Q3)	p value*
FPG, mg/dL	Atorvastatin	-3.5 (-21.7–6.7)*	0.42	0.03
	Rosuvastatin	- 6.5 (-13.0–3.0)	0.17
	Pitavastatin	-19.0 (-40.0– -1.5)	<0.001
HbA1c, %	Atorvastatin	-0.10 (-0.5–0.2)*	0.53	0.01
	Rosuvastatin	0.20 (-0.8–0.5)*	0.40
	Pitavastatin	-0.75 (-1.3–0.1)	0.01

FPG, fasting plasma glucose; HbA1c, glycated hemoglobin.

^*Wilcoxon sign test; ^†Kruskal-Wallis test. For other explanations see previous table.